# Context Therapeutics Inc.: Form 8-K, filed Feb 27, 2026

- Company: [Context Therapeutics Inc.](/companies/cntx.md) (CIK 1842952)
- Form: 8-K
- Filed: 2026-02-27
- Accepted by EDGAR: Feb 27, 2026, 16:11 ET
- Period: 2026-02-24
- Accession: 0001628280-26-012813
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1842952/000162828026012813/cntx-20260224.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1842952/000162828026012813/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1842952/000162828026012813/cntx-20260224.htm

Filed Feb 27, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-012813. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.